Skip to content
healthcare.dev

Isturisa

NDC 55292-320, osilodrostat, tablet, coated, from Recordati Rare Diseases, Inc..

Product NDC
55292-320
Status
Listed
Labeler
Recordati Rare Diseases, Inc.
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212801
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55292-320 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSILODROSTAT PHOSPHATE1 mg/1

Pharmacologic classes

Cortisol Synthesis Inhibitor [EPC]; Cytochrome P450 11B1 Inhibitors [MoA]; Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Cytochrome P450 3A5 Inhibitors [MoA]

Package NDCNDC-11Package
55292-320-205529203202020 TABLET, COATED in 1 BLISTER PACK (55292-320-20)
55292-320-605529203206060 TABLET, COATED in 1 BLISTER PACK (55292-320-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2

Use it

Look up 55292-320 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55292-320 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55292-320. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.